Candel Therapeutics Inc. (CADL)
NASDAQ · Healthcare
Candel Therapeutics Inc. Long Term Debt 2020–2022
Candel Therapeutics Inc. annual/quarterly long term debt history from 2020 to 2021. Long term debt refers to financial obligations that are due more than one year in the future.
- Candel Therapeutics Inc. long term debt for the quarter ending December 31, 2021 were 560,000, a 15.94% increase year-over-year.
- Candel Therapeutics Inc. long term debt for 2021 were 560,000, a 15.94% increase from 2020.
- Candel Therapeutics Inc. long term debt for 2020 were 483,000.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Candel Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2021 | $1 |
| 2020 | $0 |
| Candel Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2021-12-31 | $1 |
| 2020-12-31 | $0 |
Candel Therapeutics Inc. Long Term Debt — FAQ
Candel Therapeutics Inc. (CADL) long term debt over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CADL's long term debt history?
The chart and table above show Candel Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.